| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | CATALYST | 78,622 | 757,000 | 0.17% | ||
| 2 | ACURA PHARMACEUTICALS INC | 1,956,397 | 1,177,000 | 0.27% | ||
| 3 | LIGAND PHARMACEUTICALS INC | 30,996 | 3,281,000 | 0.75% | ||
| 4 | MEDICINOVA INC | 1,170,370 | 7,011,000 | 1.60% | ||
| 5 | ENDOLOGIX INC | 1,257,468 | 14,484,000 | 3.30% | ||
| 6 | CORIUM INTERNATIONAL INC | 9,353,304 | 39,097,000 | 8.92% | ||
| 7 | ENTELLUS MED INC | 3,231,656 | 44,597,000 | 10.18% | ||
| 8 | AXOGEN INC | 4,861,111 | 50,799,000 | 11.59% | ||
| 9 | REVANCE THERAPEUTICS INC COM | 4,592,047 | 95,515,000 | 21.79% | ||
| 10 | ABIOMED INC | 1,450,000 | 181,540,000 | 41.42% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001398344-17-006361, filed 2017.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
